We found that, in 117 patients with CHB-HCC, patients with preoperative serum detectable HBV DNA had higher AFP concentrations, longer tumour diameter, a higher percent of macrovascular invasion, microvascular invasion, and poorer TNM stage, and a higher proportion of extended OLT criteria than those with undetectable HBV DNA. This evidence concerns the gene AFP and hepatocellular carcinoma.